HMMR and breast carcinoma: The cell membrane receptor hyaluronan-mediated motility receptor (HMMR), which is linked to the Glycosaminoglycan hyaluronic acid (HA), is significantly expressed in a variety of malignant tumors, including breast cancer, stomach carcinoma, bladder cancer, prostate carcinoma, colorectal cancer, and others [13–17].